Synergism of peptide receptor-targeted Auger electron radiation therapy with anti-angiogenic compounds in a mouse model of neuroendocrine tumors. - Wikidata - awgldk - TriplyDB

Synergism of peptide receptor-targeted Auger electron radiation therapy with anti-angiogenic compounds in a mouse model of neuroendocrine tumors.

Synergism of peptide receptor-targeted Auger electron radiation therapy with anti-angiogenic compounds in a mouse model of neuroendocrine tumors.

http://www.wikidata.org/entity/Q37607383

about

Combining antiangiogenic therapy and radiation in nasopharyngeal carcinoma.

P2860

Q38489938-4433B4CB-3203-4EAC-A191-63CB8A68DD4A

P2860

Synergism of peptide receptor-targeted Auger electron radiation therapy with anti-angiogenic compounds in a mouse model of neuroendocrine tumors.

http://www.wikidata.org/entity/Q37607383

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 16 February 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Synergism of peptide receptor- ...... odel of neuroendocrine tumors.

@en

Synergism of peptide receptor- ...... odel of neuroendocrine tumors.

@nl

type

label

Synergism of peptide receptor- ...... odel of neuroendocrine tumors.

@en

Synergism of peptide receptor- ...... odel of neuroendocrine tumors.

@nl

prefLabel

Synergism of peptide receptor- ...... odel of neuroendocrine tumors.

@en

Synergism of peptide receptor- ...... odel of neuroendocrine tumors.

@nl

P1433

Q37607383-6744D2CC-803E-4359-9D25-49A59E5CFE03

P1476

Q37607383-9D97A858-D48D-4A36-97D4-D4E8CE59C890

P2093

Q37607383-3D1A8B58-FD11-4279-95F8-FF97D83FEF7C

Q37607383-4646F1FA-4583-4331-939D-2246BDD2987B

Q37607383-7D359081-3B50-4940-B987-AB34CEA4381F

Q37607383-A8183043-8B91-4F69-A86A-EE9222A4CF30

Q37607383-BF062AF7-4DAE-4AA3-A81B-62D0AF9A864B

Q37607383-C7473FFF-4852-417C-AE7F-DB9E84FE806B

Q37607383-D47DBE21-1F55-4D95-B88B-2B613340AAAF

Q37607383-E05B5FDC-83C4-4C97-97B8-174F68284FC9

P2860

Q37607383-04CE7BFB-6515-4B5B-A7D0-02672C4CE225

Q37607383-1509C213-7D61-4260-A99C-A99131BD809C

Q37607383-1D60001A-3E2C-4B49-8C6C-01A3EAF76629

Q37607383-2092F8AB-1A0B-49C6-9484-4760AB6C0BC3

Q37607383-322660B7-043E-48DE-B492-D4AAE2BB146D

Q37607383-35844CF8-7761-4536-9DED-F99D286AAD5F

Q37607383-3872352F-2DAF-4125-93E1-DE3403C98755

Q37607383-3E0BABA4-7E92-4BD7-8A13-88177391AFC7

Q37607383-3F9A82AE-C32B-4EC5-B9C3-254B51B8474D

Q37607383-4505673E-1CDA-4467-A7D7-AB335AAD3800

P2888

Q37607383-E0D71E4B-D388-4FAC-9A53-C09768C9333F

P304

Q37607383-2DF8788D-4F02-470E-AFF2-2CF7DBDBD0D2

P31

Q37607383-D3698041-B6AD-4FA3-AB9A-7FD81CB9101E

P356

Q37607383-9D79F089-E800-4E76-A707-D7E5739D2DB5

P433

Q37607383-3B4AF180-9D1E-49FE-BEE3-63CEBFA13818

P478

Q37607383-18CB0AFE-BEB9-47F6-A561-283F4FCE717D

P50

Q37607383-8EC13A6B-D611-4F4A-BAEC-48188AC0E681

Q37607383-D01EE8B5-F1FA-482A-9F2E-77EBF11E8F8F

P577

Q37607383-379362AF-D695-4444-AAA9-8E64B5293FB9

P5875

Q37607383-184DCC9A-0FB7-410D-9403-3EEFBBACBADF

P6179

Q37607383-AC777178-ED1C-48B8-8942-631EC06D02E3

P698

Q37607383-A39006AF-67A6-4E31-B798-7EDF3A6A0E28

P921

Q37607383-C27C7FD8-2DD5-44CB-AB04-6238FB59B386

P932

Q37607383-8682ED70-FBD0-4754-B800-6089041DA107

P356

P1433

EJNMMI Research

P1476

Synergism of peptide receptor- ...... odel of neuroendocrine tumors.

@en

P2093

Annette Orleth

http://www.w3.org/2001/XMLSchema#string

Christoph Rochlitz

http://www.w3.org/2001/XMLSchema#string

Damian Wild

http://www.w3.org/2001/XMLSchema#string

Gerhard Christofori

http://www.w3.org/2001/XMLSchema#string

Helmut R Mäcke

http://www.w3.org/2001/XMLSchema#string

Jean-Claude Reubi

http://www.w3.org/2001/XMLSchema#string

Rosalba Mansi

http://www.w3.org/2001/XMLSchema#string

Vincent Prêtre

http://www.w3.org/2001/XMLSchema#string

P2860

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin

Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton

Combined anti-angiogenic therapy targeting PDGF and VEGF receptors lowers the interstitial fluid pressure in a murine experimental carcinoma

Vascular endothelial growth factor and its receptors, flt-1 and flk-1, are expressed in normal pancreatic islets and throughout islet cell tumorigenesis

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors

Effect of antivascular endothelial growth factor treatment on the intratumoral uptake of CPT-11.

Recent advances in research on multistage tumorigenesis.

Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.

P2888

P304

9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/2191-219X-4-9

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Christoph Mamot

P577

2014-02-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260216553

http://www.w3.org/2001/XMLSchema#string

P6179

1045751635

http://www.w3.org/2001/XMLSchema#string

P698

24528513

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

3937006

http://www.w3.org/2001/XMLSchema#string